3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
5
Thoracic
2
Breast
2
Tumor-Agnostic
1
Sarcoma
1
Plasma cell
1
Other
1
Lymphoid
1
Gastrointestinal
1
Dermatologic
1
Conditions
Sarcoma
1
Interventions
Blood Specimen Collection
14
Surveys and Questionnaires
13
Surgical Procedures, Operative
12
Gene Expression Profiling
10
Observation
7
Amplified Fragment Length Polymorphism Analysis
7
Polymerase Chain Reaction
6
Drug Therapy
6
Radiotherapy
5
Microarray Analysis
5
Immunohistochemistry
5
Psychiatric Rehabilitation
4
Imatinib Mesylate
4
Base Sequence
4
regorafenib
3
Trabectedin
3
Tissue Banks
3
Therapeutics
3
Sunitinib
3
Specimen Handling
3
Reverse Transcriptase Polymerase Chain Reaction
3
Radiation
3
Methods
3
Magnetic Resonance Imaging
3
Interviews as Topic
3
Doxorubicin
3
Biopsy
3
ripretinib
2
mifamurtide
2
Watchful Waiting
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Urine Specimen Collection
×
Sarcoma
×
Clear all
NCT06482957
2025-09-19
CAUSAL
Vanderbilt-Ingram Cancer Center
Recruiting
2,100 enrolled